Exercise
|
Phase
|
GMed
|
UGMax
|
LGMax
|
BF
|
---|
NCA
|
ECA
|
P-value
|
NCA
|
ECA
|
P-value
|
NCA
|
ECA
|
P- value
|
NCA
|
ECA
|
P-value
|
---|
Clam
|
Concentric
|
12.27 (6.79)
|
14.89 (5.93)
|
0.026a, b
|
35.37 (19.68)
|
33.01 (25.50)
|
0.405
|
4.90 (3.42)
|
5.81 (4.33)
|
0.071
|
1.75 (1.33)
|
2.41 (2.00)
|
0.008b
|
Isometric
|
15.63 (10.53)
|
18.39 (10.66)
|
0.002b
|
50.41 (37.42)
|
51.07 (35.56)
|
0.796
|
5.28 (3.60)
|
5.71 (4.16)
|
0.219
|
2.12 (1.42)
|
3.44 (3.18)
|
0.033b
|
Eccentric
|
7.27 (4.48)
|
10.48 (5.92)
|
0.007b
|
20.50 (15.52)
|
24.12 (18.38)
|
0.088
|
3.04 (2.03)
|
3.94 (1.93)
|
0.003b
|
1.87 (1.24)
|
4.64 (3.83)
|
0.001b
|
HABD
|
Concentric
|
27.52 (9.1)2
|
31.38 (12.02)
|
0.057a
|
29.06 (23.31)
|
30.20 (22.30)
|
0.728
|
3.75 (2.38)
|
4.80 (3.85)
|
0.058
|
1.08 (0.72)
|
1.86 (1.20)
|
0.005b
|
Isometric
|
28.89 (7.92)
|
31.20 (10.10)
|
0.096
|
39.63 (28.29)
|
42.91 (27.47)
|
0.466
|
4.19 (2.67)
|
4.88 (3.24)
|
0.058
|
0.98 (0.55)
|
1.70 (1.05)
|
0.003b
|
Eccentric
|
14.89 (5.02)
|
19.33 (5.94)
|
0.004a, b
|
17.97 (14.69)
|
19.56 (10.51)
|
0.353
|
2.79 (1.76)
|
3.63 (2.11)
|
0.004b
|
1.03 (0.68)
|
1.88 (0.86)
|
<0.001b
|
PHE
|
Concentric
|
15.81 (10.28)
|
20.24 (10.57)
|
0.002b
|
14.82 (5.47)
|
19.74 (9.12)
|
0.002a, b
|
20.09 (8.00)
|
25.62 (16.68)
|
0.071
|
12.26 (5.66)
|
17.23 (12.28)
|
0.019b
|
Isometric
|
22.15 (14.90)
|
30.28 (15.84)
|
<0.001b
|
22.87 (9.21)
|
30.98 (16.51)
|
0.004b
|
26.62 (10.82)
|
36.01 (22.27)
|
0.013b
|
15.27 (7.91)
|
20.30 (12.21)
|
0.008b
|
Eccentric
|
10.97 (6.32)
|
12.92 (4.40)
|
0.121
|
12.32 (4.43)
|
16.62 (4.46)
|
<0.001a, b
|
11.73 (4.27)
|
14.56 (7.12)
|
0.021b
|
9.47 (4.50)
|
12.25 (8.20)
|
0.074
|
-
BF Biceps femoris, ECA Enhanced core activation, HABD Hip abduction, GMed Gluteus medius, LGMax Lower part of gluteus maximus, NCA Natural core activation, PHE Prone hip extension, UGMax Upper part of gluteus maximus. aindicates paired t-test otherwise Wilcoxon Signed rank test was used and bindicates significant difference between two core conditions